Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Payton Weltge
Institutions:
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute,
Pelotonia,
The Ohio State University
Observed institutions:
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute,
Pelotonia,
The Ohio State University
ORCID:
0000-0001-9404-6744
Observed ORCID:
0000-0001-9404-6744
OpenAlex ID:
A5050480234
Androgen conspires with the CD8 + T cell exhaustion program and contributes to sex bias in cancer
2022
·
Hyunwoo Kwon
, Johanna M. Schafer
, et al.
·
Science Immunology
·
268
PDF
Targeting TGFβ docking receptor glycoprotein A repetitions predominant (GARP) via novel chimeric antigen receptor (CAR)-T cell platform to treat glioblastoma
2025
·
Bill Xingjun Wu
, Daniel Kreatsoulas
, et al.
·
Neuro-Oncology
·
8
PDF
Novel mechanisms of androgen receptor-centered transcriptional regulatory network in regulating CD8+ T cell exhaustion and sex bias in cancer
2023
·
Tong Xiao
, Johanna Schafer
, et al.
·
The Journal of Immunology
·
2
PDF
The chromatin-organizer Satb1 modulates regulatory T cell activity within the tumor microenvironment
2026
·
Ephraim A. Ansa-Addo
, Parviz Azimnasab-Sorkhabi
, et al.
·
Nature Communications
PDF
GARP+ Erythroid Regulatory Cells (G-ERCs) define spatially organized immunosuppressive niches that restrain anti-tumor immunity 2259805
2026
·
Maria Velegraki
, Jordan Krull
, et al.
·
The Journal of Immunology
Developing Novel Bispecific T-cell Engager Therapy by Concurrent Targeting GARP on Cancer Cells and Regulatory T cells 2258672
2026
·
Ziyu Wang
, Yaa Amankwah
, et al.
·
The Journal of Immunology
ZFP148 is a transcriptional repressor of cytolytic effector CD8+ T cell differentiation
2026
·
Tong Xiao
, Xingyu Chen
, et al.
·
Nature Immunology
Garp/LRRC32 defines the erythroid-megakaryocyte fate decision and enables β-globin program activation
2025
·
Maria Velegraki
, Bradley Blaser
, et al.
·
Blood
PDF
Loss of the Y chromosome defines a biologically distinct subtype of Acute Myeloid Leukemia (AML), associated with decreased inflammatory response patterns, and favorable outcomes in young male patients (pts)
2025
·
Maria Velegraki
, Cankun Wang
, et al.
·
Blood
Heightened protein synthesis and aggregation, coupled with futile protein quality control, underlie a novel mechanism of CD8+ T cell exhaustion 3479
2025
·
Yi Wang
, Anjun Ma
, et al.
·
The Journal of Immunology
PDF
ZFP148 is a transcriptional checkpoint for effector CD8+ T cell differentiation 3939
2025
·
Tong Xiao
, Xingyu Chen
, et al.
·
The Journal of Immunology
PDF
Characterization of Sole Loss of the Y Chromosome and Associated Effects on Adaptive Immunity in Adult Male Patients with Acute Myeloid Leukemia (AML)
2024
·
Maria Velegraki
, Cankun Wang
, et al.
·
Blood
PDF
934 ZFP148 represses effector differentiation and cytotoxicity of CD8+ T cells during chronic viral infection and cancer
2024
·
Tong Xiao
, Xingyu Chen
, et al.
·
Journal for ImmunoTherapy of Cancer
Show more works
View as search
Works count:
13
Citation count:
278
H-index:
2
I10-index:
1
Year
Topic
Type